Biohit Oyj’s Financial Reporting and Annual Gene
Post# of 301275
Biohit Oyj Stock Exchange Release, December 5, 2016 at 3:00 pm local time (EET)
- Biohit Oyj will release its financial statements for 2016 on Monday 20 th of February 2017 at 9:30 am.
- The Annual Report, which contains the Financial Statements for 2016 and the Report of the Board of Directors, will be published approximately during week 12.
- Biohit Oyj’s Annual General Meeting has been planned for Wednesday 26 th of April 2017 at 5:00 pm. The Board of Directors will call the General Meeting at a later date.
- Half year financial report for period January-June (H1) 2017 on Thursday 17 th of August 2017 at 9:30 am.
The published economic reports and other stock exchange releases are available on Biohit's website at www.biohithealthcare.com/investors . The website also contains an online form for ordering electronic copies, which will be e-mailed to you, available at http://www.biohithealthcare.com/investors/sto...your-email .
Additional information: CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 investor.relations@biohit.fi www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com
(0)
(0)